| Literature DB >> 32431276 |
Eugene Ruberanziza1,2, Udo Wittmann3,4, Aimable Mbituyumuremyi2, Alphonse Mutabazi2,5, Carl H Campbell6, Daniel G Colley6,7, Fiona M Fleming3, Giuseppina Ortu3, Govert J van Dam8, Irenee Umulisa9, Jamie Tallant10, Michee Kabera2,11, Muhammed Semakula12, Paul L A M Corstjens8, Tharcisse Munyaneza13, Warren Lancaster10, Jean Bosco Mbonigaba1,2, Michelle N Clements3,14.
Abstract
The field standard for the detection of Schistosoma mansoni infection is Kato-Katz (KK), although it misses many active infections, especially light infections. In 2014, a reassessment of S. mansoni prevalence was conducted in Rwanda using the more sensitive point-of-care circulating cathodic antigen (POC-CCA) rapid assay. A total of 19,371 children from 399 schools were selected for testing for single urine CCA. Of these, 8,697 children from 175 schools were also tested with single stool double-slide KK. Samples from eight of these 175 schools were tested again with CCA and additionally with the highly specific and sensitive up-converting phosphor-lateral flow circulating anodic antigen (UCP-LF CAA) assay. Latent class analysis was applied to all four test results to assess sensitivity and specificity of POC-CCA and estimate the proportion of trace results from Rwanda likely to be true infections. The overall prevalence of S. mansoni infection in Rwanda when CCA trace results were considered negative was 7.4% (school interquartile range [IQR] 0-8%) and 36.1% (school IQR 20-47%) when trace was considered positive. Prevalence by KK was 2.0% with a mean intensity of infection of 1.66 eggs per gram. The proportion of active infections among children diagnosed with CCA trace was estimated by statistical analysis at 61% (Bayesian credibility interval: 50-72%). These results indicate that S. mansoni infection is still widespread in Rwanda and prevalence is much underestimated by KK testing. Circulating cathodic antigen is an affordable alternative to KK and more suitable for measuring S. mansoni prevalence in low-intensity regions.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32431276 PMCID: PMC7356434 DOI: 10.4269/ajtmh.19-0866
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345
Figure 1.Creation of Rwanda mapping units for Schistosoma mansoni infections. Five-kilometer buffer zones were created around permanent water bodies and wetlands (as far as information was available), shown in orange in the top of the figure (A). Contiguous groups of sectors inside the same 5-km buffer zone were grouped into high-risk mapping units, whereas contiguous sectors with little or no area in buffer zones were grouped into low-risk mapping units. The bottom figure (B) shows the distribution of high- and low-risk mapping units.
Summary statistics from the three different datasets analyzed
| Dataset | POC-CCA mapping | POC-CCA and KK comparison | Assessment with CAA in Leiden | |
|---|---|---|---|---|
| Number of schools | 388 | 175 | 8 | |
| Number of pupils | 19,371 | 8,697 | 396 | |
| Age of pupils (years), mean (SD) | 13.4 (0.75) | 13.3 (0.75) | 13.4 (0.67) | |
| Percentage female | 50.1 | 49.9 | 50.0 | |
| Prevalence, % (school IQR) | CCA trace negative in Rwanda | 7.4 (0.0–8.0) | 8.6 (1.0–8.0) | 31.3 (32.0 –37.1) |
| CCA trace positive in Rwanda | 36.1 (20.0–47.0) | 37.5 (22.0–49.0) | 65.7 (64.0–78.5) | |
| Kato–Katz in Rwanda | – | 2.0 (0.0–0.0) | 8.1 (3.0–11.2) | |
| CCA trace negative in Leiden | – | – | 33.8 (25.5–47.8) | |
| CCA trace positive in Leiden | – | – | 55.8 (50.0–75.0) | |
| CAA in Leiden | – | – | 44.2 (31.0–63.5) | |
IQR = interquartile range; KK= Kato–Katz; POC-CCA = point-of-care circulating cathodic antigen. The 175 schools assessed by POC-CCA (CCA) and KK were a subset of the 388 schools assessed using POC-CCA, and the eight purposively selected schools also assessed by POC-CCA and CAA in Leiden were a subset of the 175 schools assessed with POC-CCA and KK in Rwanda. Variability between schools was reported as IQR of the school prevalence estimates. Note that 81% of schools sampled recorded no infections by KK.
Figure 2.Prevalence of Schistosoma mansoni by point-of-care circulating cathodic antigen (POC-CCA) results and by mapping unit. H and L denotes mapping unit as high- or low-risk units of S. mansoni, respectively, as determined before the survey. Prevalence by POC-CCA trace negative can be read off the top of the black bars, whereas prevalence by POC-CCA trace positive can be read off the top of the grey bars. Mapping units were sorted by prevalence, low to high, with trace as negative.
Modeling the prevalence of Schistosoma mansoni infections controlling for gender, age, and the risk status of the mapping unit, that is, proximity to perennial water body
| POC-CCA trace negative | POC-CCA trace positive | ||||||
|---|---|---|---|---|---|---|---|
| 19,317 pupils, 388 schools | 19,317 pupils, 388 schools | ||||||
| All POC-CCA mapping schools | |||||||
| Fixed effects | Levels | Parameter | Adjusted odds ratio | Parameter | Adjusted odds ratio | ||
| Intercept | −3.44 (0.18) | 0.03 (0.02, 0.05) | < 0.001 | −0.69 (0.12) | 0.5 (0.4, 0.63) | < 0.001 | |
| Gender | F | – | – | – | – | – | – |
| M | 0.31 (0.06) | 1.36 (1.21, 1.53) | < 0.001 | 0.08 (0.033) | 1.09 (1.02, 1.16) | 0.013 | |
| Age.s | 0.04 (0.035) | 1.04 (0.97, 1.12) | 0.246 | −0.03 (0.02) | 0.97 (0.94, 1.01) | 0.14 | |
| Age.s2 | −0.05 (0.022) | 0.95 (0.91, 0.99) | 0.024 | −0.01 (0.01) | 0.99 (0.97, 1.01) | 0.439 | |
| Risk | High risk | – | – | – | – | – | – |
| Low risk | −0.7 (0.32) | 0.5 (0.26, 0.94) | 0.031 | −0.11 (0.22) | 0.90 (0.59, 1.38) | 0.6247 | |
| Random effects | |||||||
| Variance | SD | Variance | SD | ||||
| Mapping unit (intercept) | 0.43 | 0.66 | 0.21 | 0.46 | – | ||
| School (intercept) | 2 | 1.4 | 0.95 | 0.98 | – | ||
POC-CCA = point-of-care circulating cathodic antigen.
Estimates of sensitivity and specificity of the four diagnostic tests applied to the urine samples from eight selected schools which were also assayed at the Leiden University Medical Center
| POC-CCA trace negative | POC-CCA trace positive | |
|---|---|---|
| Sensitivity (%) (95% BCI) | ||
| Kato–Katz in Rwanda | 14.1 (8.3, 19.8) | 2.5 (0.2%, 6.6%) |
| CCA in Rwanda | 46.1 (35.6, 56.1) | 82.5 (77.6%, 86.9%) |
| CCA in Leiden | 94.2 (85.3%, 99.5%) | 93.6 (89.0%, 97.3%) |
| CAA in Leiden | 97.0 (90.6%, 99.8%) | 90.5 (83.6%, 96.9%) |
| Covariance KK and CAA | 0.6 (0.0%, 2.2%) | 0.3 (0.0%, 1.0%) |
| Covariance CCAR and CCAL | 7.0 (3.2%, 11.2%) | – |
| Specificity (%) (95% BCI) | ||
| Kato–Katz in Rwanda | 98.2 (95.0, 99.8) | 98.9 (97.1%, 99.9%) |
| CCA in Rwanda | 85.3 (80.4%, 90.6) | 53.5 (50.0%, 57.6%) |
| POC-CCA in Leiden | 85.9 (80.3%, 92.3%) | 98.2 (94.4%, 99.9%) |
| CAA in Leiden | 83.1 (77.9%, 87.7%) | 49.2 (45.8%, 54.2%) |
| Covariance KK and CAA | 12.1 (8.9%, 15.3%) | 21.9 (19.2%, 23.8%) |
| Covariance CCAR and CCAL | 10.3 (6.8%, 13.6%) | – |
| PPV of CCA in Rwanda (%) (95% BCI) | ||
| Trace as negative | 68.3 (58.0, 78.5) | – |
| Trace as positive | 64.5 (59.9%, 68.9%) | – |
| Trace | 61.6 (50.1%, 72.1%) | – |
BCI = Bayesian credibility interval; POC-CCA = point-of-care circulating cathodic antigen.
Infection prevalence estimated by the latent class analysis and the differences to the prevalences estimated by each diagnostic test
| Trace negative | Trace positive | |||||||
|---|---|---|---|---|---|---|---|---|
| Mean | SD | LBCI | UBCI | Mean | SD | LBCI | UBCI | |
| Infection prevalence (%) | 40.7 | 2.5 | 35.8 | 45.8 | 50.6 | 2.0 | 46.7 | 54.5 |
| Estimated prevalence (%) | ||||||||
| Kato–Katz in Rwanda | 8.1 | 1.3 | 5.6 | 10.9 | 8.1 | 1.3 | 5.6 | 10.9 |
| POC-CCA in Rwanda | 31.3 | 2.2 | 27.0 | 35.6 | 65.7 | 1.9 | 61.9 | 69.4 |
| POC-CCA in Leiden | 33.8 | 2.1 | 29.8 | 38.1 | 55.8 | 2.1 | 51.8 | 59.8 |
| CAA in Leiden | 44.3 | 2.1 | 40.2 | 48.5 | 44.2 | 2.1 | 40.2 | 48.2 |
| Estimated test—disease prevalence (%) | ||||||||
| Kato–Katz in Rwanda | −32.6 | 2.9 | −38.3 | −27.1 | −42.5 | 2.4 | −47.2 | −37.8 |
| POC-CCA in Rwanda | −9.4 | 3.4 | −16.1 | −2.7 | 15.1 | 2.8 | 9.6 | 20.6 |
| POC-CCA in Leiden | −6.9 | 3.3 | −13.4 | −0.5 | 5.3 | 2.9 | −0.2 | 11.0 |
| CAA in Leiden | 3.6 | 3.3 | −2.9 | 10.2 | −6.4 | 2.9 | −11.7 | −0.7 |
Figure 4.Estimated test prevalence against estimated disease prevalence when circulating cathodic antigen trace was considered negative (left) and positive (right). Estimates are from the output of a Bayesian latent class analysis and the cloud of dots for each test show 1,000 estimates from the posterior distribution.